These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
55 related articles for article (PubMed ID: 23880517)
21. [Endogenous cannabinoid system and depression]. Yu HL; Zhang F; Quan ZS Sheng Li Ke Xue Jin Zhan; 2012 Aug; 43(4):257-62. PubMed ID: 23189618 [TBL] [Abstract][Full Text] [Related]
22. Endocannabinoids rein in pain outside the brain. Lovinger DM Nat Neurosci; 2010 Oct; 13(10):1155-6. PubMed ID: 20877276 [TBL] [Abstract][Full Text] [Related]
23. PET and SPECT in drug evaluation and drug design imaging inflammatory processes, tumors, and the endocannabinoid system. van Waarde A Curr Pharm Des; 2008; 14(31):3295-6. PubMed ID: 19075708 [No Abstract] [Full Text] [Related]
24. Endocannabinoids and psychopathology: the therapy inside. Drago F Pharmacol Res; 2007 Nov; 56(5):357-9. PubMed ID: 17942319 [No Abstract] [Full Text] [Related]
25. Preface. Parsons L; Hill M Int Rev Neurobiol; 2015; 125():xi-xii. PubMed ID: 26638770 [No Abstract] [Full Text] [Related]
26. Identification of Novel Predictive Biomarkers for Endometrial Malignancies: Ayakannu T; Taylor AH; Marczylo TH; Maccarrone M; Konje JC Front Oncol; 2019; 9():430. PubMed ID: 31245282 [No Abstract] [Full Text] [Related]
27. Downstream effects of endocannabinoid on blood cells: implications for health and disease. Gasperi V; Evangelista D; Savini I; Del Principe D; Avigliano L; Maccarrone M; Catani MV Cell Mol Life Sci; 2015 Sep; 72(17):3235-52. PubMed ID: 25957591 [TBL] [Abstract][Full Text] [Related]
28. TRPV1 mediates cellular uptake of anandamide and thus promotes endothelial cell proliferation and network-formation. Hofmann NA; Barth S; Waldeck-Weiermair M; Klec C; Strunk D; Malli R; Graier WF Biol Open; 2014 Nov; 3(12):1164-72. PubMed ID: 25395667 [TBL] [Abstract][Full Text] [Related]
29. Inhibition of COX-2-mediated eicosanoid production plays a major role in the anti-inflammatory effects of the endocannabinoid N-docosahexaenoylethanolamine (DHEA) in macrophages. Meijerink J; Poland M; Balvers MG; Plastina P; Lute C; Dwarkasing J; van Norren K; Witkamp RF Br J Pharmacol; 2015 Jan; 172(1):24-37. PubMed ID: 24780080 [TBL] [Abstract][Full Text] [Related]
30. Cognitive and neuropsychiatric consequences of endocannabinoid signaling dysfunction. Solowij N; Monterrubio S Neuropsychopharmacology; 2006 Feb; 31(2):471-2. PubMed ID: 16421518 [No Abstract] [Full Text] [Related]
31. Update on the endocannabinoid system as an anticancer target. Malfitano AM; Ciaglia E; Gangemi G; Gazzerro P; Laezza C; Bifulco M Expert Opin Ther Targets; 2011 Mar; 15(3):297-308. PubMed ID: 21244344 [TBL] [Abstract][Full Text] [Related]
32. The endocannabinoid system: a general view and latest additions. De Petrocellis L; Cascio MG; Di Marzo V Br J Pharmacol; 2004 Mar; 141(5):765-74. PubMed ID: 14744801 [TBL] [Abstract][Full Text] [Related]
33. Endocannabinoid-mediated control of synaptic transmission. Kano M; Ohno-Shosaku T; Hashimotodani Y; Uchigashima M; Watanabe M Physiol Rev; 2009 Jan; 89(1):309-80. PubMed ID: 19126760 [TBL] [Abstract][Full Text] [Related]
34. Endocannabinoid signaling in cancer: a rather complex puzzle. Maccarrone M Trends Pharmacol Sci; 2013 Aug; 34(8):426-7. PubMed ID: 23880517 [No Abstract] [Full Text] [Related]